ImmuPharma(GB:IMM)
GBX 2.82+0.13 (+5.03%)
GB:IMM
ImmuPharma financials statements
GBX 2.82
At close:+0.13 (+5.03%)
Want to see GB:IMM full AI Analyst Report?
ImmuPharma (IMM) Income Statement
34 Followers
ImmuPharma Income Statement
Last quarter (Q2 2026), ImmuPharma's total revenue was £0.00. In Q2, ImmuPharma's net income was £-4.70M. See ImmuPharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 118.35K | |
| £ -35.30K | £ -63.88K | £ -37.61K | £ -118.00K | £ 118.35K | |
| £ 2.51M | £ 2.67M | £ 3.06M | £ 2.91M | £ 6.71M | |
| Depreciation and Amortization | £ 35.30K | £ 63.88K | £ 37.61K | £ 117.56K | £ 114.12K |
| £ -2.51M | £ -2.61M | £ -3.02M | £ -2.91M | £ -8.70M | |
| £ -2.54M | £ -2.68M | £ -3.06M | £ -3.03M | £ -6.59M | |
| £ 370.56K | £ -104.00K | £ -356.00K | £ -1.43M | £ -2.35M | |
| £ -2.17M | £ -2.78M | £ -3.42M | £ -4.46M | £ -8.94M | |
| £ -1.81M | £ -2.48M | £ -2.92M | £ -3.81M | £ -8.17M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.00 | £ -0.01 | £ -0.01 | £ -0.01 | £ -0.03 |
| Diluted EPS | £ -0.00 | £ -0.01 | £ -0.01 | £ -0.01 | £ -0.03 |
| Weighted Average Shares Outstanding | 490.59M | 413.92M | 360.71M | 302.91M | 251.16M |
| Weighted Average Shares Outstanding (Diluted) | 490.59M | 416.44M | 362.00M | 302.91M | 251.16M |
Currency in GBP

